Structural floor intact but momentum negative; maintain passive exposure without scaling, hedging, or trim until Q3 earnings catalyst
The HOLD consensus is correct as a passive, capital-preserving posture — not a coiled spring and not a complex execution overlay. The asymmetry is mildly upside on the first leg ($1,126 to $1,089 = 37 points downside vs $1,183 = 57 points upside, 1.54:1) but roughly even on the full path (worst case to $1,051 = 74 points, 0.77:1). The 54% EPS-growth path required to justify 17.5x forward multiple and $62.6B goodwill exceeding $57.6B book equity (tangible book ~negative $5B) do not justify fresh capital deployment, but the untested 200 SMA at $1,051 preserves the structural floor and prevents exit. Complex execution (scaled adds, trailing stops, put overlays) is explicitly rejected per 8/27 and 9/2 lessons showing friction destroys alpha on intact compounders. Single-tier triggers govern re-rating; Q3 earnings (~mid-October) is the resolution catalyst.
| Position | Action |
|---|---|
| Current positioning | Maintain existing exposure unchanged |
BLK's long-term business thesis remains intact despite short-term technical weakness; the stock offers a high-quality, cash-generative compounder at an improving forward valuation with multiple secular growth engines.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 1142.62 | bearish |
| 50 SMA | 1089.07 | bullish |
| 200 SMA | 1052.22 | bullish |
| RSI (14) | 48.27 | neutral |
| MACD Line | 10.14 | bearish |
| MACD Signal | 19.48 | bearish |
| MACD Histogram | −9.34 | bearish |
| BB Upper | 1192.99 | neutral |
| BB Middle | 1153.12 | neutral |
| BB Lower | 1113.24 | bullish |
| ATR (14) | 23.83 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Upgrade to Overweight for starter add at 1.5-2.0:1 risk/reward
Forward valuation is reasonable at 17.51x earnings with a 0.95 PEG ratio
↩ rebuts: “Bear '27 times earnings is too expensive' argument”
· concedes: Short-term tape is weak with deteriorating momentum indicators; MACD histogram at -9.34 reflects post-rally unwind; Price below 10-day EMA and VWMA; Vanguard/Altruist development is a competitive risk; Goodwill and negative tangible book value are legitimate monitoring points; Stock underperformed the Dow; Low retail interest reduces sentiment as a catalyst; Forward estimates are not guarantees
BLK is a high-quality business but not a high-quality stock at current price; the risk-reward is negative given lost momentum, stretched valuation requiring heroic growth, hostile macro with hike risk and multiple compression pressure, and balance sheet risks from $62.6B in goodwill against negative tangible book.
· concedes: BLK is a high-quality business with real competitive advantages; Price > 50 SMA > 200 SMA hierarchy is technically true; The 50 SMA ($1,089) is 37 points below price, providing some structural support if tested; BLK's BUIDL fund is current scale leader in tokenization; Some earnings beats are real (Q2 2026 +20% YoY); Partnership model is genuinely asset-light and scalable
→ vs conservative: The conservative analyst misreads the MACD histogram at minus 9.34 as a danger signal when in a high-quality compounder like BLK, deeply negative readings at pullback bottoms are exhaustion signals that historically mark capitulation rather than continuation; the 1.425 beta and hawkish FOMC risks are largely priced in given 89 percent full-year no-cut probability
→ vs neutral: The neutral analyst waiting for RSI above 55 and price above 1142.62 on volume will miss 30 to 50 dollars of upside by the time clarity arrives; the 54 percent implied EPS growth to hit 64.31 forward estimate is not demanding given 30.6 percent recent revenue growth, EBITDA margin expansion, and 20 percent net income growth plus raised buybacks in Q1 2026
| VWMA (20) | 1154.12 | bearish |
Support: 1113.24 · 1089.07 · 1052.22 | Resistance: 1142.62 · 1153.12 · 1192.99
The technical analysis rates BLK as HOLD, with a neutral-to-bearish short-term bias as price tests the lower Bollinger Band at 1113.24 while momentum indicators (MACD histogram −9.34, RSI 48.27) confirm a cooling pullback phase. The long-term uptrend structure remains intact with price comfortably above both the 50 SMA (1089.07) and 200 SMA (1052.22), and a tactical buy zone is identified near the 50 SMA if support holds. Key invalidation levels are 1089 on the downside and 1142.62 (10 EMA) for trend recovery.
Market Cap
$182.97 B
Share Price (TTM avg basis)
~$1,126
52-Week High
$1,219.94
52-Week Low
$917.39
Beta
1.425
P/E (TTM)
26.98x
Forward P/E
17.51x
PEG Ratio
0.95
Price / Book
3.03x
Dividend Yield
2.07%
EPS (TTM)
$41.74
Forward EPS
$64.31
TTM Revenue
$27.3 B
TTM Net Income
$6.58 B
Profit Margin (TTM)
24.1%
Operating Margin (TTM)
35.1%
Q2 2026 Total Revenue
$7,084 M
Q2 2026 Operating Expense
$996 M
Q2 2026 Operating Income
$2,461 M
Q2 2026 EBITDA
$3,238 M
Q2 2026 Net Income
$1,914 M
Q2 2026 Diluted EPS
$12.19
TTM EBITDA
$11.12 B
TTM Gross Profit
$12.87 B
Return on Equity (ROE)
12.3%
Return on Assets (ROA)
3.7%
Q2 2026 Total Assets
$175,875 M
Q2 2026 Total Equity (Common)
$57,613 M
Q2 2026 Goodwill & Intangibles
$62,618 M
Q2 2026 Total Debt
$14,968 M
Q2 2026 Net Debt
$2,252 M
Q2 2026 Cash & Equivalents
$10,492 M
Q2 2026 Working Capital
$23,659 M
Current Ratio
2.45x
Tangible Book Value
-$5.0 B
Q2 2026 Operating Cash Flow
$1,227 M
Q2 2026 CapEx
-$109 M
Q2 2026 Free Cash Flow
$1,118 M
Q2 2026 Dividends Paid
-$933 M
Q2 2026 Share Repurchases
-$461 M
TTM Free Cash Flow
$7.58 B
Equity Growth YoY
+17%
Revenue YoY Growth (Q2)
+30.6%
Net Income YoY Growth (Q2)
+20.2%
Forward EPS Growth
+54%
Strengths
Concerns
BlackRock delivered strong Q2 2026 results with revenue accelerating 30.6% YoY to $7.08B and net income of $1.91B, sustaining an elevated earnings run-rate following Q1's EPS of $14.06. The TTM profit margin of 24.1% and operating margin of 35.1% reflect best-in-class profitability for an asset manager, while $7.58B in TTM free cash flow robustly covers capital returns ($3.6B dividends + $2.2B buybacks annually). Valuation appears reasonable on forward metrics (17.5x P/E, 0.95 PEG) given 54% expected earnings growth, though trailing P/E of 27x is elevated and the stock carries significant market beta (1.425), with key risks including high goodwill ($62.6B), negative tangible book value, and sensitivity to equity market levels through fee-based revenue.